The application of 3D genomics in clinical diagnostics has been hindered by the high input requirements of standard Hi-C protocols (typically millions of cells). In Diffuse Large B-Cell Lymphoma (DLBCL), identifying structural variants (SVs) like translocations is critical for diagnosis, but patient biopsies often provide limited material. Researchers aimed to validate a low-input Hi-C method to detect pathogenic chromosomal rearrangements and TAD disruptions directly in primary patient tissue1.
The study utilized a "Low-C" protocol optimized for low-input material, applied to primary lymph node biopsies from DLBCL patients. Hi-C sequencing data was generated and integrated with Whole Genome Sequencing (WGS). The analysis pipeline focused on identifying inter-chromosomal interactions (translocations) and mapping changes in local chromatin insulation (TADs) associated with oncogene dysregulation2.
The Hi-C analysis successfully reconstructed the 3D genome from the low-input clinical samples. Most notably, the interaction matrices revealed clear structural variations that linear sequencing could often miss or misinterpret structurally.
Figure 1. Detection of chromosomal translocations by Hi-C. The contact map displays a distinct off-diagonal interaction hotspot (butterfly pattern) representing the t(14;18) translocation, which fuses the BCL2 gene with the IGH locus. This structural event is a hallmark driver of the lymphoma.
The Hi-C data provided a distinct visual signature for the t(14;18) translocation. Furthermore, the 3D maps revealed that this rearrangement altered the local chromatin insulation, effectively placing the BCL2 oncogene under the regulatory control of the highly active IGH super-enhancers.
This study confirms that Low-Input Hi-C is a robust tool for analyzing clinical samples. It provides a dual advantage: identifying large-scale structural variants with high precision and revealing the 3D regulatory consequences (enhancer hijacking) of these rearrangements. This establishes Hi-C as a viable assay for precision oncology, even when sample quantity is limited4.



Genome-wide Interaction Heatmap
A/B Compartments & Gene Expression
TAD Identification & Differential Boundaries
Significant Loop Analysis